EUVIMEDEUVIMED entdecken
Crossref

CB2R-cAMP-Epac1 pathway orchestrates epithelial–neural–immune interactions in atopic dermatitis

Ximin Hu, Yi Luo, Yiya Zhang, Kun Liu, Liyan Wu, Jinjun Hou, Guodun Zhao, Ting Wang, Yifei Liu, Hongyi Cheng, Xia Li, Lei Zhang und 7 weitere

Journal of Allergy and Clinical Immunology · 2025

DOI: 10.1016/j.jaci.2025.08.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2025. Verfasst von Ximin Hu und 18 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Shanghai, China; Department of Burn and Plastic Surgery, Guangzhou Fi…. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Receptor, Cannabinoid, CB2, Keratinocytes, Cyclic AMP. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Shanghai Municipal Natural Science Foundation, Shanghai Rising-Star Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Keratinocytes form the skin's first line of defense, not only serving as a physical barrier but also actively communicating with immune cells and sensory neurons. OBJECTIVE: This study elucidated the molecular mechanisms by which keratinocytes contribute to barrier dysfunction and neuroimmune activation in atopic dermatitis (AD). METHODS: Cannabinoid receptor 2 (CB2R) expression was assessed by RNA sequencing, quantitative reverse transcription PCR (qRT-PCR), RNAscope fluorescence, and Western blot analysis. Pharmacologic activation/inhibition or keratinocyte-specific deletion of CB2R was used to determine its role in AD-associated itch and inflammation. Behavioral assays, immunofluorescence, and qRT-PCR were used to identify downstream signaling components. RESULTS: CB2R expression was upregulated in the epidermis of MC903-induced AD. CB2R activation alleviated scratching and skin pathology, whereas keratinocyte-specific CB2R deletion exacerbated both. CB2R suppressed adenylate cyclase 3 activity, reducing cAMP levels and downstream Epac1 activation, thereby limiting IL-33 production. This CB2R-cAMP-Epac1-IL-33 axis regulated epidermal hyperplasia, dermal neutrophil infiltration, and chronic itch. CONCLUSION: The keratinocyte CB2R-cAMP-Epac1 axis integrates epithelial, neural, and immune signaling to drive AD pathology, representing a potential therapeutic target for chronic itch and skin inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicReceptor, Cannabinoid, CB2KeratinocytesCyclic AMPGuanine Nucleotide Exchange FactorsAnimalsMiceSignal TransductionHumansInterleukin-33Mice, Inbred C57BLDisease Models, AnimalSkinMice, Knockout

Stichwörter der Autor:innen

Atopic dermatitisCB2REpac1chronic itchkeratinocyte

Substanzen

Receptor, Cannabinoid, CB2Cyclic AMPGuanine Nucleotide Exchange FactorsCnr2 protein, mouseInterleukin-33

Autor:innen und Institutionen

  • State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Shanghai, China; Department of Burn and Plastic Surgery, Guangzhou First People's Hospital, South China University of Technology, Guangzhou…
  • State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Shanghai, China; Department of Plastic and Reconstructive Surgery, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicin…
  • Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China; Hunan Key Laboratory of Aging Biology, Xiangya Hospital, Central South University, Changsha, China; National Clinical Research Cent…
  • Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing, China.
  • State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Shanghai, China.
  • State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Shanghai, China; National Engineering Research Center of TCM Standardization Technology, Shanghai Institute of Materia Medica, Chinese Acad…

Förderung

  • Shanghai Municipal Natural Science Foundation
  • Shanghai Rising-Star Program
  • National Natural Science Foundation of China
  • Chinese Academy of Sciences
  • National Key Research and Development Program of China Stem Cell and Translational Research
  • Shanghai Municipal Health Commission
  • National Key Research and Development Program of China

Zitieren

APA

Hu, X., Luo, Y., Zhang, Y., Liu, K., Wu, L., Hou, J., Zhao, G., Wang, T., Liu, Y., Cheng, H., Li, X., Zhang, L., Liu, L., Wu, W., Yang, R., Gao, X., Li, J., Xu, H., & Feng, J. (2025). CB2R-cAMP-Epac1 pathway orchestrates epithelial–neural–immune interactions in atopic dermatitis. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2025.08.021

Vancouver

Hu X, Luo Y, Zhang Y, Liu K, Wu L, Hou J, et al. CB2R-cAMP-Epac1 pathway orchestrates epithelial–neural–immune interactions in atopic dermatitis. Journal of Allergy and Clinical Immunology. 2025. doi:10.1016/j.jaci.2025.08.021

BibTeX
@article{Hu2025,
  author = {Hu, Ximin and Luo, Yi and Zhang, Yiya and Liu, Kun and Wu, Liyan and Hou, Jinjun and Zhao, Guodun and Wang, Ting and Liu, Yifei and Cheng, Hongyi and Li, Xia and Zhang, Lei and Liu, Libei and Wu, Wanying and Yang, Ronghua and Gao, Xinyan and Li, Ji and Xu, Heng and Feng, Jing},
  title = {CB2R-cAMP-Epac1 pathway orchestrates epithelial–neural–immune interactions in atopic dermatitis},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2025},
  doi = {10.1016/j.jaci.2025.08.021}
}
Kostenlos starten →